CSIMarket Company Name, Ticker, Competitors, else..
 
Athenex Inc   (NASDAQ: ATNX)
 

ATNX's Market share relative to its competitors, as of Q4 2022

As of Q4 2022 (Revenue in Millions of $)

Date modified: 2026-05-18T05:46:34+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q4 2022		 MARKET SHARE
12 Months
Q4 2022		 MARKET SHARE
MRQ
Q4 2022		 MARKET SHARE
A Quarter Before
Q3 2022
Athenex Inc 102.82 23.53% 7.51 % 17.19 %
Spectrum Pharmaceuticals Inc 109.33 25.03% 14.56% 5.18%
Wave Life Sciences Ltd 81.75 18.71% 2.12% 19.60%
Cti Biopharma Corp 75.77 17.34% 22.48% 10.81%
Mersana Therapeutics inc 33.18 7.59% 10.26% 1.57%
Tracon Pharmaceuticals Inc 11.13 2.55% 0.05% 0.05%
20 more competitors available

Sign in to see all competitors for Athenex Inc .

Sign In Create Free Account



ATNX's Market share relative to its competitors, as of Q4 2022 within the Major Pharmaceutical Preparations Industry
As of Q4 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2022		 MARKET SHARE
12 Months Ending
Q3 2022		 MARKET SHARE
MRQ
Q4 2022		 MARKET SHARE

Q3 2022
Athenex Inc 24.70% 25.58% 7.68 % 17.40 %
Spectrum Pharmaceuticals Inc 26.26% 23.37% 14.89% 5.25%
Wave Life Sciences Ltd 19.64% 28.67% 2.17% 19.85%
Cti Biopharma Corp 18.20% 11.53% 23.00% 10.94%
Mersana Therapeutics inc 7.97% 7.43% 10.50% 1.59%
Aravive Inc 1.68% 1.97% 2.63% 0.66%
16 more companies available

Sign in to see all industry competitors for Athenex Inc .

Sign In Create Free Account



ATNX's Market share relative to its competitors, as of Q4 2022 within the Healthcare Sector
As of Q4 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2022		 MARKET SHARE
12 Months Ending
Q3 2022		 MARKET SHARE
MRQ
Q4 2022		 MARKET SHARE

Q3 2022
Athenex Inc 23.53% 24.62% 7.51 % 17.19 %
Spectrum Pharmaceuticals Inc 25.03% 22.49% 14.56% 5.18%
Wave Life Sciences Ltd 18.71% 27.59% 2.12% 19.60%
Cti Biopharma Corp 17.34% 11.10% 22.48% 10.81%
Mersana Therapeutics inc 7.59% 7.15% 10.26% 1.57%
Tracon Pharmaceuticals Inc 2.55% 1.80% 0.05% 0.05%
20 more companies available

Sign in to see all sector competitors for Athenex Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Athenex Inc's market divisions, geographic dispersion, segments, products, and services, visit Athenex Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.